Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 1987 Feb;33:385–388.

Hyposensitization Therapy

Arthur Leznoff
PMCID: PMC2218338  PMID: 21263828

Abstract

Hyposensitization therapy is useful in the treatment of allergic disease causing rhinoconjunctivitis and asthma, and in the prophylaxis against anaphylaxis to hymenoptera stings. It may be of value in some patients with drug sensitivities. Its effectiveness has been proven by objective clinical studies, and the immune mechanisms responsible for patients' response have been demonstrated in vivo and in vitro. A prerequisite for effectiveness is the identification of the offending antigen and the availability of that antigen in a standardized, purified, stable extract. Modified antigens with special immunologic properties show much promise for the future.

Keywords: allergy, hyposensitization

Full text

PDF
385

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson M. C., Baer H., Ohman J. L., Jr A comparative study of the allergens of cat urine, serum, saliva, and pelt. J Allergy Clin Immunol. 1985 Oct;76(4):563–569. doi: 10.1016/0091-6749(85)90776-6. [DOI] [PubMed] [Google Scholar]
  2. Asherson G. L., Zembala M., Perera M. A., Mayhew B., Thomas W. R. Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the peyer's patches, mesenteric lymph nodes and other lymphoid tissues. Cell Immunol. 1977 Sep;33(1):145–155. doi: 10.1016/0008-8749(77)90142-3. [DOI] [PubMed] [Google Scholar]
  3. Austen K. F. Tissue mast cells in immediate hypersensitivity. Hosp Pract (Off Ed) 1982 Nov;17(11):98–108. doi: 10.1080/21548331.1982.11702416. [DOI] [PubMed] [Google Scholar]
  4. Berkelman R. L., Finton R. J., Elsea W. R. Beta-adrenergic antagonists and fatal anaphylactic reactions to oral penicillin. Ann Intern Med. 1986 Jan;104(1):134–134. doi: 10.7326/0003-4819-104-1-134_1. [DOI] [PubMed] [Google Scholar]
  5. Boulet L. P., Cartier A., Thomson N. C., Roberts R. S., Dolovich J., Hargreave F. E. Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol. 1983 Apr;71(4):399–406. doi: 10.1016/0091-6749(83)90069-6. [DOI] [PubMed] [Google Scholar]
  6. Bousquet J., Calvayrac P., Guérin B., Hejjaoui A., Dhivert H., Hewitt B., Michel F. B. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol. 1985 Nov;76(5):734–744. doi: 10.1016/0091-6749(85)90680-3. [DOI] [PubMed] [Google Scholar]
  7. Fink J. N. Immunotherapy of asthma. J Allergy Clin Immunol. 1985 Aug;76(2 Pt 2):402–404. doi: 10.1016/0091-6749(85)90662-1. [DOI] [PubMed] [Google Scholar]
  8. Georgitis J. W., Nickelsen J. A., Wypych J. I., Kane J. H., Reisman R. E. Local nasal immunotherapy: efficacy of low-dose aqueous ragweed extract. J Allergy Clin Immunol. 1985 Apr;75(4):496–500. doi: 10.1016/s0091-6749(85)80023-3. [DOI] [PubMed] [Google Scholar]
  9. Gleich G. J., Zimmermann E. M., Henderson L. L., Yunginger J. W. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. J Allergy Clin Immunol. 1982 Oct;70(4):261–271. doi: 10.1016/0091-6749(82)90062-8. [DOI] [PubMed] [Google Scholar]
  10. Golden D. B., Meyers D. A., Kagey-Sobotka A., Valentine M. D., Lichtenstein L. M. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy. J Allergy Clin Immunol. 1982 Jun;69(6):489–493. doi: 10.1016/0091-6749(82)90172-5. [DOI] [PubMed] [Google Scholar]
  11. Grammer L. C., Shaughnessy M. A., Patterson R. Modified forms of allergen immunotherapy. J Allergy Clin Immunol. 1985 Aug;76(2 Pt 2):397–401. doi: 10.1016/0091-6749(85)90661-x. [DOI] [PubMed] [Google Scholar]
  12. Ishizaka K. Cellular events in the IgE antibody response. Adv Immunol. 1976;23:1–75. doi: 10.1016/s0065-2776(08)60318-1. [DOI] [PubMed] [Google Scholar]
  13. Ishizaka K., Okudaira H., King T. P. Immunogenic properties of modified antigen E. II. Ability of urea-denatured antigen and alpha-polypeptide chain to prime T cells specific for antigen E. J Immunol. 1975 Jan;114(1 Pt 1):110–115. [PubMed] [Google Scholar]
  14. Metzger W. J., Turner E., Patterson R. The safety of immunotherapy during pregnancy. J Allergy Clin Immunol. 1978 Apr;61(4):268–272. doi: 10.1016/0091-6749(78)90202-6. [DOI] [PubMed] [Google Scholar]
  15. Murray A. B., Ferguson A. C., Morrison B. J. Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy. Ann Allergy. 1985 Jun;54(6):541–544. [PubMed] [Google Scholar]
  16. Möller C., Dreborg S., Lanner A., Björkstén B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study. Allergy. 1986 May;41(4):271–279. doi: 10.1111/j.1398-9995.1986.tb02028.x. [DOI] [PubMed] [Google Scholar]
  17. Nickelsen J. A., Georgitis J. W., Mueller U. R., Kane J., Wypych J. I., Goldstein S., Reisman R. E., Arbesman C. E. Local nasal immunotherapy for ragweed-allergic rhinitis. III. A second year of treatment. Clin Allergy. 1983 Nov;13(6):509–519. doi: 10.1111/j.1365-2222.1983.tb02632.x. [DOI] [PubMed] [Google Scholar]
  18. Norman P. S. An overview of immunotherapy: implications for the future. J Allergy Clin Immunol. 1980 Feb;65(2):87–96. doi: 10.1016/0091-6749(80)90191-8. [DOI] [PubMed] [Google Scholar]
  19. Norman P. S., Lichtenstein L. M., Kagey-Sobotka A., Marsh D. G. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever. J Allergy Clin Immunol. 1982 Oct;70(4):248–260. doi: 10.1016/0091-6749(82)90061-6. [DOI] [PubMed] [Google Scholar]
  20. Ohman J. L., Jr, Findlay S. R., Leitermann K. M. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. J Allergy Clin Immunol. 1984 Sep;74(3 Pt 1):230–239. doi: 10.1016/0091-6749(84)90251-3. [DOI] [PubMed] [Google Scholar]
  21. Pleskow W. W., Stevenson D. D., Mathison D. A., Simon R. A., Schatz M., Zeiger R. S. Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol. 1982 Jan;69(1 Pt 1):11–19. doi: 10.1016/0091-6749(82)90081-1. [DOI] [PubMed] [Google Scholar]
  22. Randolph C. C., Reisman R. E. Evaluation of decline in serum venom-specific IgE as a criterion for stopping venom immunotherapy. J Allergy Clin Immunol. 1986 Jun;77(6):823–827. doi: 10.1016/0091-6749(86)90379-9. [DOI] [PubMed] [Google Scholar]
  23. Reisman R. E., Dvorin D. J., Randolph C. C., Georgitis J. W. Stinging insect allergy: natural history and modification with venom immunotherapy. J Allergy Clin Immunol. 1985 Jun;75(6):735–740. doi: 10.1016/0091-6749(85)90103-4. [DOI] [PubMed] [Google Scholar]
  24. Rocklin R. E., Sheffer A. L., Greineder D. K., Melmon K. L. Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med. 1980 May 29;302(22):1213–1219. doi: 10.1056/NEJM198005293022201. [DOI] [PubMed] [Google Scholar]
  25. Sehon A. H. Specific suppression of IgE antibodies. An immunotherapeutic goal achievable in the foreseeable future. J Allergy Clin Immunol. 1978 Nov;62(5):257–260. doi: 10.1016/0091-6749(78)90155-0. [DOI] [PubMed] [Google Scholar]
  26. Sullivan T. J. Antigen-specific desensitization of patients allergic to penicillin. J Allergy Clin Immunol. 1982 Jun;69(6):500–508. doi: 10.1016/0091-6749(82)90174-9. [DOI] [PubMed] [Google Scholar]
  27. Terr A. I. Environmental illness. A clinical review of 50 cases. Arch Intern Med. 1986 Jan;146(1):145–149. doi: 10.1001/archinte.146.1.145. [DOI] [PubMed] [Google Scholar]
  28. Van Metre T. E., Jr, Adkinson N. F., Jr, Lichtenstein L. M., Mardiney M. R., Jr, Norman P. S., Jr, Rosenberg G. L., Sobotka A. K., Valentine M. D. A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever. J Allergy Clin Immunol. 1980 Apr;65(4):288–297. doi: 10.1016/0091-6749(80)90158-x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES